NIPT available as standard option for all pregnant women from 1 April From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.
No new SARS-CoV-2 variants discovered in wastewater on aircraft from China Wastewater on aircraft from China has not been found to contain any new variants of the coronavirus SARS-CoV-2 so far. These findings are from several tests performed by RIVM. However, the wastewater was found to contain coronavirus particles.
Provisional figures on participation in the National Immunisation Programme According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).
More attention needed for potential impact of drug waste on drinking water quality Drug waste contains substances that are harmful to the quality of drinking water. Because this waste is dumped illegally, these substances can end up in sources of drinking water.
Incorrect emission factors used for some farms included in list of top 100 ammonia emitters At the request of the Dutch House of Representatives, RIVM compiled a list of the 100 biggest ammonia emitters in the Netherlands. Recently, the underlying data used to compile this list were disclosed pursuant to a request under the Open Government Act.
Cancer screening programmes now more accessible to transgender and intersex persons Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.
RIVM creates overview of nitrogen monitoring in water in Europe At the behest of the European Parliament, the National Institute for Public Health and the Environment (RIVM) has formulated a report on how EU member states are dealing with European regulations on nitrogen in water (nitrate). Michel Looyenstein
Nationwide study into chlamydia and gonorrhoea Today, the National Institute for Public Health and the Environment (RIVM) launches a nationwide study into chlamydia and gonorrhoea.
Side effect reports National Immunisation Programme 2021 Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.